Live Breaking News & Updates on Infectious Disease Create

Stay updated with breaking news from Infectious disease create. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PharmaDrug Inc.: PharmaDrug Advances Programs in Oncology with Filing of PCT Application Detailing the Use of PD-001 for Treatment of Prostate Cancer

Toronto, Ontario (Newsfile Corp. - January 31, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development ....

United States , Wangy Cepharanthine , Daniel Cohen , Baillyc Cepharanthine , Newsfile Corp , Development Paths For Oncology , Pharmadrug Inc , Drug Administration , Patent Cooperation Treaty , Set Forth , Centered Around Demonstrated Benefit , Pre Clinical Prostate Cancer , Provisional Patent , Validated Studies Support Potential , Development Paths , Infectious Disease Create , Enteric Coated Oral Cepharanthine , Sairiyo Therapeutics , Regarding Forward Looking Information , Profi Marcel Torney ,

PharmaDrug Advances Programs in Oncology and Infectious Disease through Completion of cGMP Drug Substance Manufacturing

Toronto - PharmaDrug Inc. , a specialty pharmaceutical company focused on the research, development and commercialization of psychedelics and other naturally-derived approved drugs, is pleased to. | October 5, 2022 ....

United States , Daniel Cohen , Development Paths For Oncology , Pharmadrug Inc , Drug Administration , Genvion Corporation , Development Paths , Infectious Disease Create , Enteric Coated Oral Cepharanthine , Validated Studies Reveal Potential , Enabling Prostate Cancer , Provisional Patent , Sairiyo Therapeutics , Super Smart , News Publishing , Pharmadrug Inc Stock Exchange , Press Release , Leased Phrx Ca71716w1059 ,

PharmaDrug Advances Programs in Oncology and Infectious Disease Through Completion of cGMP Drug Substance Manufacturing

PharmaDrug Advances Programs in Oncology and Infectious Disease Through Completion of cGMP Drug Substance Manufacturing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , South Africa , Japan General , South African , Wangy Cepharanthine , Daniel Cohen , Baillyc Cepharanthine , Newsfile Corp , Development Paths For Oncology , Pharmadrug Inc , Drug Administration , Genvion Corporation , Development Paths , Infectious Disease Create , Enteric Coated Oral Cepharanthine , Validated Studies Reveal Potential , Enabling Prostate Cancer , Provisional Patent , Enabling Esophageal Cancer , Drug Designation , Infectious Disease , Middle East , Cepharanthine May Work , Block Coronavirus , Sairiyo Therapeutics , Super Smart ,

PharmaDrug Inc.: PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Disease

Completes qualification of all necessary analytical methodologies to support production of Cepharanthine-2HCL drug substanceClinical trial-scale production of cGMP Cepharanthine-2HCL drug substance scheduled ....

United States , South Africa , Japan General , South African , Wangy Cepharanthine , Daniel Cohen , Baillyc Cepharanthine , Newsfile Corp , Development Paths For Oncology , Pharmadrug Inc , Drug Administration , Genvion Corporation , Development Paths , Infectious Disease Create , Enteric Coated Oral Cepharanthine , Validated Studies Reveal Potential , Enabling Prostate Cancer , Enabling Esophageal Cancer , Drug Designation , Infectious Disease , Middle East , Cepharanthine May Work , Block Coronavirus , Sairiyo Therapeutics , Super Smart , Regarding Forward Looking Information ,

PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Diseas

PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Diseas
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , South Africa , Japan General , South African , Wangy Cepharanthine , Daniel Cohen , Baillyc Cepharanthine , Newsfile Corp , Development Paths For Oncology , Pharmadrug Inc , Drug Administration , Genvion Corporation , Development Paths , Infectious Disease Create , Enteric Coated Oral Cepharanthine , Validated Studies Reveal Potential , Enabling Prostate Cancer , Enabling Esophageal Cancer , Drug Designation , Infectious Disease , Middle East , Cepharanthine May Work , Block Coronavirus , Sairiyo Therapeutics , Super Smart , Regarding Forward Looking Information ,